LEADER 01292nam  2200349z- 450 
001 9910689529403321
005 20161209102734.0
035   $a(CKB)5600000000079892
035   $a(BIP)008680034
035   $a(EXLCZ)995600000000079892
100   $a20211123c2002uuuu  -u-         -
101 0 $aeng
200 14$aThe status of research into vaccine safety and autism $ehearing before the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, second session, June 19, 2002
215   $a1 online resource (iv, 672 p.) $cill
311   $a0-16-069244-X 
517   $aStatus of research into vaccine safety and autism 
606   $aAutism in children$xEtiology
606   $aVaccination$xComplications$xResearch$zUnited States
606   $aVaccines$xSafety measures
610   $aAutism
610   $aVaccination
610   $aVaccines
610   $aPsychology
610   $aMedical
615  0$aAutism in children$xEtiology.
615  0$aVaccination$xComplications$xResearch
615  0$aVaccines$xSafety measures.
712 02$aUnited States, Congress House Committee on Government Reform Staff,$4oth
906   $aBOOK
912   $a9910689529403321
996   $aThe status of research into vaccine safety and autism$93199959
997   $aUNINA